Brandes US Small-Mid Cap Value ETF(BSMC.US)

Last Updated 19:00:00 ET
longbridge loading
Company Encyclopedia
View More
name
Brandes US Small-Mid Cap Value ETF
BSMC.US
News
View More

Dentsply Sirona Highlights Connected Dentistry and Growth Strategy in New Presentation

Dentsply Sirona Inc. presented at the 2026 J.P. Morgan Healthcare Conference, showcasing its leadership in connected dentistry and digital dental solutions. The company serves over 100 countries, trains over 400,000 dental professionals annually, and has launched over 50 new products in four years. Key segments include Essential Dental Solutions and Connected Technology Solutions. The presentation highlighted the company's return-to-growth action plan, focusing on streamlining workflows and promoting digital dentistry adoption.

Reuters·
US
XRAY
+1.81%
Reuters·
US
XRAY
+1.81%

Dentsply Sirona Expands Technology Partnership With Benco Dental

Dentsply Sirona Inc. and Benco Dental have expanded their partnership, allowing Benco Dental to offer Dentsply Sirona’s dental technology solutions, including the CEREC system and intraoral scanners, to US customers. This collaboration enhances Benco Dental’s role as a distributor of Dentsply Sirona’s products and aims to improve access to integrated digital dentistry solutions.

Reuters·
US
XRAY
+1.81%
Reuters·
US
XRAY
+1.81%

Elanco Secures USDA Approval For Befrena, Expands Dermatology Portfolio

Elanco Animal Health Inc. has received USDA approval for Befrena, a new anti-IL31 monoclonal antibody injection for treating canine allergic and atopic dermatitis. Recommended every 6 to 8 weeks, Befrena offers a longer treatment interval than its competitor, lokivetmab. The product is set to launch in the first half of 2026, marking Elanco's second dermatology product approval in 18 months. Elanco's stock closed at $22.63, down 0.57%, and further declined to $22.16 in after-hours trading.

rttnews·
US
ELAN
-0.04%
rttnews·
US
ELAN
-0.04%

Dentsply Sirona Updates Multiple Financing Agreements With Major Lenders

Dentsply Sirona has updated its financing agreements with major lenders, including a Second Amendment to its revolving credit agreement and three Note Purchase Agreement amendments, all effective December 24, 2025. These changes aim to enhance covenant flexibility, maintain compliance, and align terms across various financing agreements. Key adjustments include resetting leverage ratio thresholds, adding restrictions on payments, and refining debt definitions. Management anticipates these steps will support liquidity and preserve flexibility in financial operations.

TradingView·
US
XRAY
+1.81%
TradingView·
US
XRAY
+1.81%

Dentsply Sirona Amends Credit and Note Agreements to Modify Debt Definitions and Covenant Terms

Dentsply Sirona Inc. has amended its corporate loan and financing agreements, obtaining lender consent for a Second Amendment to its revolving credit facility with JPMorgan Chase Bank. The amendments modify the definition of "Debt" to exclude swap obligations from leverage ratio calculations and include interest rate adjustments based on leverage thresholds. These changes aim to help the company maintain compliance with its debt covenants.

Reuters·
US
XRAY
+1.81%
Reuters·
US
XRAY
+1.81%
© 2026 Longbridge｜Disclaimer